| ADCC | Antibody-dependent cellular cytotoxicity |
| Asn | Asparagine |
| Asp | Aspartate |
| BLA | Biologics license application |
| CDC | Complement-dependent cytotoxicity |
| CDR | Complementarity-determining region |
| CHO | Chinese hamster ovary |
| CEX | Cation exchange chromatography |
| cIEF | Capillary isoelectric focusing |
| CMC | Chemistry, manufacturing, and controls |
| CQA | Critical quality attribute |
| Cys | Cysteine |
| DOE | Design of experiment |
| Fab | Fragment antigen binding |
| Gln | Glutamine |
| Glu | Glutamate |
| ICH | The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use |
| IND | Investigational New Drug |
| IEF | Isoelectric focusing |
| IEX | Ion exchange chromatography |
| LC-MS | Liquid chromatography-mass spectrometry |
| Lys | Lysine |
| Met | Methionine |
| NGNA | N-Glycolylneuraminic acid |
| PAM | Peptidyl glycine α-amidating monooxygenase |
| PD | Pharmacodynamics |
| PK | Pharmacokinetics |
| PPQ | Process performance qualification |
| PyroGlu | Pyroglutamate |
| WCX | Weak cation exchange |